From Breakdown to Breakthrough: Immunoproteasomes Could Revolutionize Immunotherapies.

The immunoproteasome (iCP), a specialized isoform of the constitutive proteasome that is often expressed or upregulated in diseased cells, has quickly become an attractive drug target. With the iCP playing a major role in the generation of MHC-I comp…

Preview only. Read the full abstract at the source